Skip to main content
Article thumbnail
Location of Repository

Differential usage of alternate promoters of the human stress response gene ATF3 in stress response and cancer cells

By Keisuke Miyazaki, Shoko Inoue, Kazuhiko Yamada, Masashi Watanabe, Qin Liu, Toshiki Watanabe, Mimi Tamamori Adachi, Yujiro Tanaka and Shigetaka Kitajima

Abstract

Stress response gene ATF3 plays a pleiotropic role in determining cell fate in response to mitogenic or stress stimuli. An alternate promoter of the human ATF3 gene (designated P1 in this study) has recently been reported, which is located ∼43.5 kb upstream of the previously reported P2 promoter. We showed here that the P1 promoter is highly conserved between human and mouse and is functional in response to various stimuli, whereas the P1 promoter was dominantly induced by serum and the P2 promoter was more efficiently activated in response to TGF-β and oncogenic HRAS. The P1 promoter contains multiple transcriptional start sites, and the different 5′-UTRs markedly affected their translation in response to stress. In human prostate and Hodgkin Reed–Sternberg cancer cells with elevated expression of ATF3, the P1 promoter was constitutively activated and its chromatin structure was modified into active configuration. The differential usage of alternate promoters of the ATF3 gene at both transcriptional and translational level and the modification of chromatin structure may provide a novel mechanism for expressing ATF3 in determining cell fate during stress response and cancer

Topics: Molecular Biology
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:2655689
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1999). A 500-bp region, 40kb upstream of the human CYP19 (aromatase) gene, mediates placenta-specific expression in transgenic mice.
    2. (2008). A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development.
    3. (2003). A self-enabling TGFb response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells.
    4. (2006). Activating transcription factor 3 and early growth response-1 are the novel targets of LY294002 in a PI3K independent pathway.
    5. (2001). Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes.
    6. (2008). Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation.
    7. (2007). Activation of the ATF3 gene through a co-ordinated amino acidsensing response programme that controls transcriptional regulation 1450
    8. (1989). An alternate promoter in the glucokinase gene is active in the pancreatic b cell.
    9. (1994). ATF3 and ATF3deltaZip. Transcriptional repression versus activation by alternatively spliced isoform.
    10. (1999). ATF3 and stress responses.
    11. (1996). ATF3 gene. Genomic organization, promoter, and regulation.
    12. (2002). ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cell growth.
    13. (2008). ATF3 regulates MCMV infection in mice by modulating IFN-gamma expression in natural killer cells.
    14. (2006). ATF3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis.
    15. (2000). CART classification of human 50 UTR sequences.
    16. (2006). Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
    17. (2003). Complex controls: the role of alternative promoters in mammalian genomes.
    18. (2006). Diversification of transcriptional modulation: large scale identification and characterization of putative alternative promoters of human genes.
    19. (2007). Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells.
    20. (2003). Expression of the activating transcription factor ATF3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and akt activation.
    21. (2000). Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH2 terminal kinase and promoter response element.
    22. (1995). Human fibroblast growth factor 1 gene expression in vascular smooth muscle cells is modulated via an alternate promoter in response to serum and phorbol ester.
    23. (1996). Identification of a lipopolysaccharide inducible transcription factor in murine macrophages.
    24. (1991). Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver.
    25. (2006). p53/-63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    26. (1951). Protein measurement with the folin phenol reagent.
    27. (2005). Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation.
    28. (2008). Stress-induced translation of ATF5 mRNA is regulated by the 50-untranslated region.
    29. (2006). Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.
    30. (2006). The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer.
    31. (2008). The functional consequences of alternative promoter use in mammalian genomes.
    32. (1991). The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serumstimulated 3T3 cells and identification of 41 novel immediate-early genes.
    33. (2002). The Paf1 complex physically and functionally associates with transcription elongation factors in vivo.
    34. (2007). The regulation of ATF3 gene expression by mitogen-activated protein kinases.
    35. (1999). The transcriptional program in the response of human fibroblasts to serum.
    36. (2006). The tumor metastasis suppressor gene Drg-1 down-regulates the expression of ATF3 in prostate cancer.
    37. (1997). Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney.
    38. (2001). Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
    39. (2002). Transcriptional activation of the human stressinducible transcriptional repressor ATF3 gene promoter by p53.
    40. (2005). Transcriptional interference - a crash course.
    41. (2002). Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription.
    42. (2006). Virtues and woes of AchE alternative splicing in stress-related neuropathologies.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.